Anti‐inflammatories and mucociliary clearance therapies in the age of CFTR modulators
Lucy Perrem(Children's Health Ireland at Crumlin), Félix Ratjen(Boston Children's Hospital)
Cited by 29
Related Papers
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>
|New England Journal of Medicine|2015|1.6k
The Effect of Chronic Infection With Aspergillus fumigatus on Lung Function and Hospitalization in Patients With Cystic Fibrosis
|CHEST Journal|2009|372
Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues
|Journal of Cystic Fibrosis|2024|77
Effect of L-arginine infusion on airway NO in cystic fibrosis and primary ciliary dyskinesia syndrome
|European Respiratory Journal|1999|69
Lung Clearance Index to Track Acute Respiratory Events in School-Age Children with Cystic Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2020|50